A new treatment strategy for stage III lung cancer presenting with airway obstruction: neoadjuvant endobronchial intratumoral chemotherapy (EITC)

F. Celikoglu, S. I. Celikoglu, E. P. Goldberg (Istanbul, Turkey; Gainesville, United States Of America)

Source: Annual Congress 2009 - Biopsy techniques
Session: Biopsy techniques
Session type: Thematic Poster Session
Number: 631
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Celikoglu, S. I. Celikoglu, E. P. Goldberg (Istanbul, Turkey; Gainesville, United States Of America). A new treatment strategy for stage III lung cancer presenting with airway obstruction: neoadjuvant endobronchial intratumoral chemotherapy (EITC). Eur Respir J 2009; 34: Suppl. 53, 631

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cryotherapy plus chemotherapy or radiation offers increased survival and quality of life in advanced stage lung cancer patients with endobronchial obstruction: Analysis of 160 patients treated with the rigid bronchoscope
Source: Annual Congress 2012 - Mediastinum and tracheobronchial tree
Year: 2012

Prodromal face of a study: High dose rate endobronchial brachytherapy (HDERB) as a first step introductory treatment of a multimodality therapy approach in non operable NSCLC with endobronchial obstruction
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012

Treatment of potentially resectable locoregional (stage III) non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005


Endobronchial intratumoral chemotherapy followed by surgery in early non-small-cell lung cancer with polypoid growth erroneously diagnosed as an advanced disease
Source: Eur Respir J 2006; 28: Suppl. 50, 610s
Year: 2006

Treatment of unresectable locoregional (stage III) non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005


Role of chemotherapy in stage III non-small cell lung cancer (NSCLC): adjuvant or induction?
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Initial combined intratumoral chemotherapy with cisplatin and irradiation for inoperable non-small cell obstructive lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 492s
Year: 2004

Carcinomatous lymphangitis of a tracheal bifurcation in lung cancer: the role of neoadjuvant chemotherapy followed by surgery
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008


A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 162s
Year: 2003

Radiotherapy and chemotherapy for elderly patients with stage I–II unresected lung cancer},
Source: Eur Respir J 2012; 40: 957-964
Year: 2012



Neo-adjuvant chemotherapy: level of evidence in early stage and in marginally resectable disease
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005

Early stage nonsmall-cell lung cancer: therapeutic options (surgery, adjuvant and neoadjuvant therapy)
Source: Annual Congress 2011 - PG10 Management of thoracic tumours in practice: a HERMES basic course
Year: 2011


Adjuvant chemotherapy and prophylactic cranial irradiation in the combined treatment for the operable patients with small cell lung cancer I-III stage
Source: Eur Respir J 2005; 26: Suppl. 49, 75s
Year: 2005

ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
Source: Eur Respir J 2009; 34: 17-41
Year: 2009



A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012


A phase III trial comparing concomitant radiochemotherapy (RT-CT) with cisplatin (P) and docetaxel (D) as induction versus consolidation in patients with locally advanced unresectable non-small cell lung cancer (NSCLC). An ELCWP study
Source: International Congress 2015 – Advances in the therapy of lung cancer
Year: 2015

Respective indications of chemotherapy, radiotherapy and surgery in limited disease stage small cell lung carcinoma
Source: Annual Congress 2005 - Neuroendocrine tumours of the lung
Year: 2005

Factors predicting complete surgical resection after induction chemotherapy in patients with initially unresectable non-small cell lung cancer (NSCLC) treated in a randomised trial
Source: Eur Respir J 2003; 22: Suppl. 45, 162s
Year: 2003

Indcution chemotherapy and radiotherapy vs. induction and simultaneous radiochemotherapy in inoperable stage III NSCLC. Update on BROCAT study CTRT 99/97
Source: Eur Respir J 2006; 28: Suppl. 50, 833s
Year: 2006

Stage I-IIIa small cell lung cancer (SCLC): multimodal therapy including surgery
Source: Eur Respir J 2001; 18: Suppl. 33, 318s
Year: 2001